glp-1 drugs and dementia Drug Fails to Quell Alzheimer's in Novo Nordisk Trials The expanding benefits of GLP-1

Chris Serres: So theyre also finding that this can help with, behavioral addictions as well

Comparison With Prior Work The integration of supported self-care interventions involving pharmacotherapy into obesity management represents a major shift that can help address the various challenges associated with weight loss and maintenance

Ferrannini G, Mellbin LG, Kirabo F, Ramasundarahettige C, Gerstein HC, Rydn L

DPP-4 inhibitors: DPP-4 inhibitors are drugs that prevent the degradation of incretin hormones, such as GLP-1 (an incretin hormone that actively contributes to blood sugar control) in the DPP-4 rich incretin pathway

Mol Immunol (2019) 116:739